Search

everythinglearnresearchcommunity

for

Search:↓

New understanding and treatments for hair loss are improving, but more research is needed.

The young woman has a benign, hereditary skin condition with no signs of a more serious syndrome.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

Kenogen increases with hair loss in women.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Men with Kennedy disease have less chance of hair loss.

Female hair loss linked to metabolic syndrome, not in males.

Aging alone barely affects the number of hair follicles, meaning hair loss is minimal without other conditions like androgenetic alopecia.

Traction may not be the only cause of cicatricial marginal alopecia.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Sex-determining genes may affect male baldness.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Blocking interferon-gamma might help treat various autoimmune diseases.